The regulatory landscape in tuberculosis integrated research platforms
European Respiratory Journal · 2026-11 · 68 (5) · 2600646
DOI: 10.1183/13993003.00646-2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 24.09.2026. Verfasst von Juan Espinosa-Pereiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Vall d'Hebron Hospital Campus, Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Tuberculosis, Antitubercular Agents, Drug Development, Biomedical Research. Die Arbeit nennt 69 Literaturangaben. Gefördert von: European Commission.
Abstract (Originalsprache)
Background
Tuberculosis (TB) is the infectious disease with the highest mortality burden globally. Despite a recently enriched drug pipeline, there has been limited progress in improving its treatment. Integrated research platforms (IRPs) provide a novel research framework which, by hosting adaptive platform trials, can streamline the evaluation of several new TB regimens, while reducing costs. However, there is no clear, evidence-based guidance on the use of IRPs for regulatory drug development in TB.
Methods
This consensus statement summarises the discussions and recommendations produced during the European Union Patient-Centric Clinical Trial Platforms (EU-PEARL) project. A multidisciplinary Task Force reviewed the literature regarding regulatory pathways for IRPs with special focus on TB and identified current gaps and needs, which were discussed by an extended panel in two consultations. Here we summarise the output of this process and propose possible ways to advance in the implementation of such platforms. Results and conclusion IRP coordinators are advised to seek early contact with national regulators and supranational bodies, including regulatory collaboration initiatives. To ensure regulatory acceptance, IRPs must prioritise careful design, including clear decision rules for phase transitions, and the development of surrogate makers. Furthermore, data leverage and stratification across groups could enhance IRP success. These efforts will not only strengthen the scientific validity of the IRP but also enhance its regulatory acceptability and impact on global TB treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Department, Vall d'Hebron Hospital Campus, Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
- Mycobacterial Infections Study Group (GEIM), Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- These authors contributed equally.
- Vita Salute San Raffaele University, Milan, Italy.
- IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID-Profile: Juan Espinosa-Pereiro, Francesca Saluzzo, Daniela Maria Cirillo
Förderung
- European Commission
Zitieren
APA
Espinosa-Pereiro, J., Saluzzo, F., González-Moreno, J., Cavaleri, M., Hittel, N., Lienhardt, C., Rombouts, K., Simonsson, U., Cirillo, D. M., & Sánchez-Montalvá, A. (2026). The regulatory landscape in tuberculosis integrated research platforms. European Respiratory Journal, 68(5), 2600646. https://doi.org/10.1183/13993003.00646-2026
Vancouver
Espinosa-Pereiro J, Saluzzo F, González-Moreno J, Cavaleri M, Hittel N, Lienhardt C, et al. The regulatory landscape in tuberculosis integrated research platforms. European Respiratory Journal. 2026;68(5):2600646. doi:10.1183/13993003.00646-2026
BibTeX
@article{EspinosaPereiro2026,
author = {Espinosa-Pereiro, Juan and Saluzzo, Francesca and González-Moreno, Jesús and Cavaleri, Marco and Hittel, Norbert and Lienhardt, Christian and Rombouts, Karin and Simonsson, Ulrika and Cirillo, Daniela Maria and Sánchez-Montalvá, Adrián},
title = {The regulatory landscape in tuberculosis integrated research platforms},
journal = {European Respiratory Journal},
year = {2026},
volume = {68},
number = {5},
pages = {2600646},
doi = {10.1183/13993003.00646-2026}
}
EUVIMED